You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Application of Topical Corticosteroids

Minna Mörtenhumer, MD; Aarne Oikarinen, MD
Department of Dermatology University of Oulu 90220 Oulu Finland

Arch Dermatol. 1985;121(8):971.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The application schedule of potent glucocorticosteroids is important for several reasons. These steroids are widely used for treatment of various dermatoses, and potent glucocorticosteroids have adverse side effects, such as atrophy1 and tachyphylaxis.2 Thus, it is important to optimize the application schedule to get maximum clinical effect with minimal side effects.

Du Vivier et al3 reported that, in mouse skin, the application of a glucocorticosteroid once every other day resulted in marked suppression of epidermal cell DNA synthesis and that the application of a steroid twice daily was not more effective. Their results suggest that, in clinical practice, one application of a glucocorticosteroid on alternate days is as effective as an application twice a day. We performed a clinical trial in psoriatic patients using both regimens.

Patients and Methods.—

Twenty-nine inpatients with psoriasis were randomly selected for participation in the trial; 28 had psoriasis . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.